BioSpace News Archive

Aerovate Therapeutics, Inc. today announced its financial results for the quarter ended June 30, 2021, and recent events.

Histogen Inc. and its partner Amerimmune, LLC today announced additional findings from its Phase 1 study of emricasan in mild symptomatic COVID-19 patients to assess safety, tolerability, and preliminary efficacy.

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that Jeff Dekker, Chief Financial Officer, will present at the Q3 Virtual Investor Summit being held August 17-18, 2021.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company committed to being the leader in responsible pain management, announced that its Board of Directors has authorized the repurchase of up to $100 million of the Company’s shares of common stock.

Cocrystal Pharma, Inc. reports financial results for the three and six months ended June 30, 2021, and provides updates on its antiviral pipeline, milestones and business activities.

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in Genomics based tests in health, wellness and serious disease, is pleased to announce the completion of its acquisition of EasyDNA (‘the acquisition’) for US$4 million in cash and stock on August 13, 2021.

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), announced today that the Medicines and Healthcare products Regulatory Agency (MHRA), the pharmaceuticals regulator in the UK, agreed with Galmed’s plan to proceed with its proposed clinical studies with Aramchol meglumine in lieu of Aramchol free acid without the need to repeat nonclinical and clinical studies other than planned limited pharmacology studies relating to Aramchol meglumine.

NeuroBo Pharmaceuticals, Inc. today announced financial results for the second quarter ended June 30, 2021 .

LENSAR, Inc. today announced that Nick Curtis, Chief Executive Officer will present at the H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021.

Axcella today announced the publication of results from the company’s AXA1125-003 clinical study in The American Journal of Gastroenterology